ES2862580T5 - Procesos de purificación por captura para proteínas expresadas en un sistema no de mamífero - Google Patents

Procesos de purificación por captura para proteínas expresadas en un sistema no de mamífero Download PDF

Info

Publication number
ES2862580T5
ES2862580T5 ES10729997T ES10729997T ES2862580T5 ES 2862580 T5 ES2862580 T5 ES 2862580T5 ES 10729997 T ES10729997 T ES 10729997T ES 10729997 T ES10729997 T ES 10729997T ES 2862580 T5 ES2862580 T5 ES 2862580T5
Authority
ES
Spain
Prior art keywords
protein
separation matrix
solution
refolding
native
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10729997T
Other languages
English (en)
Spanish (es)
Other versions
ES2862580T3 (es
Inventor
Joseph Shultz
Roger Hart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43242573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2862580(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of ES2862580T3 publication Critical patent/ES2862580T3/es
Application granted granted Critical
Publication of ES2862580T5 publication Critical patent/ES2862580T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/32—Extraction; Separation; Purification by precipitation as complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
ES10729997T 2009-06-25 2010-06-24 Procesos de purificación por captura para proteínas expresadas en un sistema no de mamífero Active ES2862580T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22047709P 2009-06-25 2009-06-25
PCT/US2010/039854 WO2010151688A2 (en) 2009-06-25 2010-06-24 Capture purification processes for proteins expressed in a non-mammalian system

Publications (2)

Publication Number Publication Date
ES2862580T3 ES2862580T3 (es) 2021-10-07
ES2862580T5 true ES2862580T5 (es) 2024-06-13

Family

ID=43242573

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10729997T Active ES2862580T5 (es) 2009-06-25 2010-06-24 Procesos de purificación por captura para proteínas expresadas en un sistema no de mamífero

Country Status (8)

Country Link
US (5) US8940878B2 (enExample)
EP (2) EP3660032B1 (enExample)
JP (1) JP2012531428A (enExample)
AU (1) AU2010266093B2 (enExample)
CA (1) CA2765154A1 (enExample)
ES (1) ES2862580T5 (enExample)
MX (1) MX2011013417A (enExample)
WO (1) WO2010151688A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5808323B2 (ja) * 2009-06-22 2015-11-10 アムジエン・インコーポレーテツド 化学的に制御されたレドックス状態を用いたタンパク質のリフォールディング
EP3660032B1 (en) 2009-06-25 2025-10-22 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
PE20130557A1 (es) 2010-03-04 2013-05-19 Pfenex Inc Metodo para producir proteinas de interferon recombinantes solubles sin desnaturalizacion
GB201506870D0 (en) 2015-04-22 2015-06-03 Ucb Biopharma Sprl Method
US20170101435A1 (en) * 2015-10-13 2017-04-13 Therapeutic Proteins International, LLC Harvesting and perfusion apparatus
IL285146B (en) * 2016-07-22 2022-09-01 Amgen Inc Methods for purifying proteins involving fc
US11697670B2 (en) 2017-08-22 2023-07-11 Biogen Ma Inc. Methods for purifying antibodies having reduced high molecular weight aggregates
US11051532B2 (en) 2017-09-22 2021-07-06 Impossible Foods Inc. Methods for purifying protein
WO2020061478A2 (en) * 2018-09-21 2020-03-26 Teneobio, Inc. Methods for purifying heterodimeric, multispecific antibodies
US12011016B2 (en) 2020-09-14 2024-06-18 Impossible Foods Inc. Protein methods and compositions
AU2021399935A1 (en) 2020-12-18 2023-06-29 Richter Gedeon Nyrt. Methods for the purification of refolded fc-peptide fusion protein

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468464A (en) 1974-11-04 1984-08-28 The Board Of Trustees Of The Leland Stanford Junior University Biologically functional molecular chimeras
US4237224A (en) 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
EP0122080B1 (en) 1983-03-25 1989-09-13 Celltech Limited A process for the production of a protein
US4468454A (en) 1983-06-10 1984-08-28 E. I. Du Pont De Nemours And Company Antifoggant process
US4572798A (en) 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
GB8508340D0 (en) 1985-03-29 1985-05-09 Creighton T E Production of protein
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
IL86090A (en) 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
CA1329119C (en) 1988-03-29 1994-05-03 Milton David Goldenberg Cytotoxic therapy
EP0719860B1 (en) 1988-05-13 2009-12-16 Amgen Inc. Process for isolating and purifying G-CSF
GB8927546D0 (en) 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5986070A (en) 1990-04-06 1999-11-16 Amgen Inc. Production of biologically active NGF proteins
EP0547102B1 (en) 1990-09-05 1998-07-08 Southern Cross Biotech Pty.Ltd. Solubilization of proteins in active forms
WO1993018136A1 (en) 1992-03-05 1993-09-16 Cytomed, Inc. Process for supporting hematopoietic progenitor cells
US5663304A (en) 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
ES2096416T3 (es) 1993-11-10 1997-03-01 Pfizer Procedimiento para el repliegue de proquimosina que comprende el reciclado de urea.
US5466377A (en) * 1994-01-19 1995-11-14 Grandics; Peter Chromatography media and their uses
IL113497A (en) 1994-04-28 2001-01-11 Amgen Inc Method for controlling metallophosphate precipitation in high cell density fermentations
AU2603995A (en) 1994-05-25 1995-12-18 University Of Nebraska Board Of Regents Biologically active glycoprotein hormones produced in procaryotic cells
WO1996040912A1 (en) 1995-06-07 1996-12-19 Amgen Inc. Ob protein compositions and method
ATE301672T1 (de) * 1996-01-23 2005-08-15 Ortho Mcneil Pharm Inc Methode zur reinigung eines erythrpoietinbindenden proteins
US5935824A (en) 1996-01-31 1999-08-10 Technologene, Inc. Protein expression system
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6180391B1 (en) 1998-01-28 2001-01-30 Amgen Inc. Highly efficient controlled expression of exogenous genes in e. coli
US6653098B1 (en) 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin
DK1066380T3 (da) 1998-05-19 2002-01-28 Avidex Ltd Opløselig T-cellereceptor
US6660843B1 (en) * 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
MXPA02000680A (es) * 1999-07-21 2002-07-02 Amgen Inc Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf.
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
NZ522847A (en) 2000-05-16 2004-11-26 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
CA2421588C (en) * 2000-09-05 2010-01-26 Amgen Inc. Tnf receptor-like molecules and uses thereof
US20070111944A1 (en) * 2001-02-16 2007-05-17 Scrofani Sergio D B Purification of vascular endothelial growth factor-B
CZ20032208A3 (cs) 2001-02-23 2004-01-14 Immunex Corporation Zvýšený výtěžek aktivních proteinů
US6972327B1 (en) * 2001-05-08 2005-12-06 Immunex Corporation Regeneration of chromatography material
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
ITMI20012345A1 (it) 2001-11-08 2003-05-08 Internat Ct For Genetic En Gin Procedimento per la produzione di interferone alfa di grado terapeutico
SI21102A (sl) 2001-12-19 2003-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika
WO2004001056A1 (en) 2002-06-24 2003-12-31 Dr. Reddy's Laboratories Ltd. Process for preparing g-csf
US7067279B1 (en) 2002-08-23 2006-06-27 Immunex Corporation Cell culture performance with betaine
EP2272864A3 (en) 2002-12-20 2011-02-16 Amgen Inc. Binding agents which inhibit myostatin
US7083948B1 (en) 2002-12-24 2006-08-01 Immunex Corporation Polypeptide purification reagents and methods for their use
EP1449848A1 (en) 2003-02-20 2004-08-25 GBF German Research Centre for Biotechnology Method for the production of cystine-knot proteins
GB0304068D0 (en) 2003-02-22 2003-03-26 Avidex Ltd Substances
ATE462716T1 (de) 2003-10-24 2010-04-15 Amgen Inc Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen
CA2554929A1 (en) 2004-01-30 2005-08-18 Amgen Inc. Process for purifying proteins
MXPA06008812A (es) 2004-02-04 2008-03-07 Neose Technologies Inc Metodo de replegamiento de glicosiltransferasas de mamiferos.
JP4765934B2 (ja) 2004-03-10 2011-09-07 大日本印刷株式会社 血管細胞培養用パターニング基板
US20050209441A1 (en) 2004-03-22 2005-09-22 Lile Jackson D Process for promoting proper folding of human serum albumin using a human serum albumin ligand
FR2874318B1 (fr) 2004-08-19 2006-11-24 Oreal Utilisation en cosmetique de composes polysaccharidiques amphoteres a chaine(s) polymerique(s) cationique(s)
ATE472333T1 (de) 2004-08-19 2010-07-15 Biogen Idec Inc Rückfaltung von proteinen der transforming-growth-factor-beta-familie
DE102004041639A1 (de) * 2004-08-27 2006-03-02 Bioceuticals Arzneimittel Ag Verfahren zur Gewinnung von biologisch aktivem humanen G-CSF aus Inclusion Bodies
WO2006036834A2 (en) † 2004-09-24 2006-04-06 Amgen Inc. MODIFIED Fc MOLECULES
US7435804B2 (en) 2004-10-19 2008-10-14 Phage Biotechnology, Inc. Method for obtaining single chain antibodies to human interferon α2b
WO2006047340A2 (en) 2004-10-22 2006-05-04 Amgen Inc. Methods for refolding of recombinant antibodies
CA2592261C (en) 2004-12-10 2015-11-24 Zymogenetics Inc. Fgf18 production in prokaryotic hosts
ES2579758T3 (es) 2005-01-28 2016-08-16 Zymogenetics, Inc. Preparaciones homogéneas de IL-31
US20080171857A1 (en) 2005-03-17 2008-07-17 Uma Devi Komath Process for the Purification of Recombinant Granulocyte-Colony Stimulating Factor
DE102005033250A1 (de) 2005-07-15 2007-01-18 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von G-CSF
US8008453B2 (en) † 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
WO2007059494A2 (en) 2005-11-14 2007-05-24 Amgen, Inc. Thermally insulated apparatus for liquid chromatographic analysis
EP1963367A4 (en) 2005-12-06 2009-05-13 Amgen Inc POLISHING STEPS IN MULTI-STAGE PROTEIN PURIFICATION TREATMENTS
EP2336164A1 (en) 2005-12-22 2011-06-22 Genentech, Inc. Recombinant production of heparin binding proteins
EP1845103B1 (en) 2006-04-10 2015-02-25 Boehringer Ingelheim RCV GmbH & Co KG Method for refolding a protein
WO2007147019A2 (en) 2006-06-13 2007-12-21 Zymogenetics, Inc. Il-17 and il-23 antagonists and methods of using the same
WO2008008975A2 (en) 2006-07-14 2008-01-17 Genentech, Inc. Refolding of recombinant proteins
WO2008011132A2 (en) 2006-07-21 2008-01-24 Amgen, Inc. Rupture valve
PE20090722A1 (es) 2007-02-02 2009-07-13 Amgen Inc Hepcidina, antagonistas de la hepcidina y metodos de uso
WO2008097829A2 (en) 2007-02-02 2008-08-14 Neose Technologies, Inc. Large scale production of eukaryotic n-acetylglucosaminyltransferase i in bacteria
WO2008096370A2 (en) 2007-02-05 2008-08-14 Natco Pharma Limited An efficient and novel purification method of recombinant hg-csf
US20080214795A1 (en) 2007-02-14 2008-09-04 Amgen Inc. Method of isolating antibodies by precipitation
BRPI0815416A2 (pt) 2007-08-15 2014-10-21 Amunix Inc Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
EP2262835A1 (en) † 2008-02-29 2010-12-22 Ramot at Tel-Aviv University Ltd. Immunoglobulin compositions and methods of producing same
PT2307454T (pt) 2008-06-25 2017-04-26 Esbatech Alcon Biomed Res Unit Anticorpos estáveis e solúveis que inibem o vegf
JP5808323B2 (ja) 2009-06-22 2015-11-10 アムジエン・インコーポレーテツド 化学的に制御されたレドックス状態を用いたタンパク質のリフォールディング
EP3660032B1 (en) 2009-06-25 2025-10-22 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
TWI648532B (zh) 2011-08-29 2019-01-21 美商安美基公司 用於非破壞性檢測-流體中未溶解粒子之方法及裝置
US8945872B2 (en) 2013-01-25 2015-02-03 Warsaw Orthopedic, Inc. Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein
CN105530949A (zh) 2013-03-15 2016-04-27 安姆根有限公司 人类受试者中的肌抑素拮抗作用
US9632095B2 (en) 2014-12-01 2017-04-25 University Of Delaware Device and method for determining reaction kinetics
US9704239B1 (en) 2016-09-02 2017-07-11 Amgen Inc. Video trigger synchronization for improved particle detection in a vessel

Also Published As

Publication number Publication date
US20200361986A1 (en) 2020-11-19
EP3660032A1 (en) 2020-06-03
CA2765154A1 (en) 2010-12-29
US11407784B2 (en) 2022-08-09
AU2010266093A1 (en) 2012-01-19
US12312381B2 (en) 2025-05-27
WO2010151688A2 (en) 2010-12-29
JP2012531428A (ja) 2012-12-10
MX2011013417A (es) 2012-03-29
AU2010266093B2 (en) 2013-06-27
EP2445924B1 (en) 2021-03-03
US10577392B2 (en) 2020-03-03
ES2862580T3 (es) 2021-10-07
US20100331526A1 (en) 2010-12-30
US20150361130A1 (en) 2015-12-17
EP2445924B2 (en) 2023-12-13
US9643997B2 (en) 2017-05-09
US8940878B2 (en) 2015-01-27
EP3660032B1 (en) 2025-10-22
US20180037603A1 (en) 2018-02-08
EP2445924A2 (en) 2012-05-02
WO2010151688A3 (en) 2011-05-19
US20230016430A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
ES2862580T5 (es) Procesos de purificación por captura para proteínas expresadas en un sistema no de mamífero
JP4826995B2 (ja) 抗体の変質を防止する精製方法
JP6385374B2 (ja) タンパク質製剤からエンドトキシンを除去するための物質および方法
US20120184711A1 (en) Novel polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin
CA2751000A1 (en) Methods of purifying small modular immunopharmaceutical proteins
ES2319844B1 (es) Procedimiento de separacion de proteinas recombinantes en sistemas acuosos de dos fases.
EP2773439A1 (en) Chromatography process for resolving heterogeneous antibody aggregates
TW201617360A (zh) 用於純化蛋白質之方法及試劑
ES2343023T3 (es) Procedimientos para purificar proteinas altamente anionicas.
Singh et al. Introduction to recombinant protein purification
Barredo et al. Protocol for bevacizumab purification using Ac-PHQGQHIGVSK-agarose
CN103608463A (zh) 由使具有免疫球蛋白折叠结构的蛋白和能够形成亚单元结构的蛋白融合而得到的单体蛋白组成的多聚体蛋白的制备方法
Scopes Purification of Special Types of Proteins